Copyright
©The Author(s) 2021.
World J Gastrointest Surg. Nov 27, 2021; 13(11): 1372-1389
Published online Nov 27, 2021. doi: 10.4240/wjgs.v13.i11.1372
Published online Nov 27, 2021. doi: 10.4240/wjgs.v13.i11.1372
Groups | “One-step” approach (n = 61) | “Step-up” approach (n = 97) | P value | |
Baseline characteristics | ||||
Sex | 0.61 | |||
Female | 19 | 34 | ||
Male | 42 | 63 | ||
Age (yr) | 52.16 ± 11.51 | 50.57 ± 13.71 | 0.45 | |
BMI (kg/m2) | 26.20 ± 3.78 | 25.91 ± 3.91 | 0.73 | |
Cause of AP | 0.36 | |||
Gallstone | 31 | 48 | ||
Alcohol | 3 | 2 | ||
Hyperlipidaemia | 15 | 34 | ||
Others | 12 | 13 | ||
Concomitant disease | 0.15 | |||
Cardiovascular disease | 29 | 37 | ||
Pulmonary disease | 8 | 13 | ||
Chronic renal insufficiency | 4 | 21 | ||
Diabetes | 13 | 16 | ||
Others | 7 | 10 | ||
ASA score | 0.42 | |||
I: Healthy status | 30 | 58 | ||
II: Mild systemic status | 30 | 38 | ||
III: Severe systemic status | 1 | 1 | ||
APACHE-II score | 13.9 ± 5.1 | 14.2 ± 5.4 | 0.71 | |
CT severity index | 6.65 ± 2.55 | 7.19 ± 2.18 | 0.18 | |
Severity of AP | 0.79 | |||
Moderately AP | 27 | 45 | ||
Severely AP | 34 | 52 | ||
Extent of pancreatic necrosis | 0.07 | |||
< 30% | 35 | 41 | ||
30%-50% | 11 | 33 | ||
> 50% | 15 | 23 | ||
Preoperative inflammatory indicators | ||||
White blood cells (109/L) | 11.04 ± 6.31 | 11.33 ± 6.03 | 0.77 | |
Neutrophil percentage (%) | 80.86 ± 8.3 | 79.57 ± 8.9 | 0.36 | |
C-reactive protein (mg/L) | 115.3 ± 81.8 | 118.5 ± 85.7 | 0.81 | |
Procalcitonin (ng/mL) | 1.18 ± 1.0 | 1.08 ± 2.2 | 0.73 | |
Interleukin 6 (pg/mL) | 113 ± 91.8 | 116 ± 95.1 | 0.93 | |
Organ failure | 0.49 | |||
Single | 10 | 14 | ||
Multiple | 5 | 14 | ||
None | 46 | 69 | ||
Time from onset of disease to admission (days) | 32.20 ± 20.75 | 53.69 ± 38.14 | < 0.001 | |
Time from onset of disease to initial surgical treatment (days) | 54.38 ± 10.46 | 76.58 ± 17.03 | < 0.001 | |
Tertiary referral (%) | 56 (91.8%) | 96 (98.9%) | 0.06 |
- Citation: Zheng Z, Lu JD, Ding YX, Guo YL, Mei WT, Qu YX, Cao F, Li F. Comparison of safety, efficacy, and long-term follow-up between “one-step” and “step-up” approaches for infected pancreatic necrosis. World J Gastrointest Surg 2021; 13(11): 1372-1389
- URL: https://www.wjgnet.com/1948-9366/full/v13/i11/1372.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i11.1372